Form 4 for CYTK CYTOKINETICS INC
Accepted 2026-01-02 00:00:00 ET · period of report 2026-01-02 · accession 0001061983-26-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-02 | 2026-01-02 | CYTK | Callos Andrew | EVP, Chief Commercial Off | S - Sale+OE | $62.62 | -1,798 | 50.4K | -3% | -$112.6K |
| D | 2026-01-02 | 2026-01-02 | CYTK | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $37.63 | +885 | 51.3K | +2% | +$33.3K |
| D | 2026-01-02 | 2026-01-02 | CYTK | Callos Andrew | EVP, Chief Commercial Off | M - OptEx | $0.00 | -885 | 1,772 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-02 | S | D | 913 | $62.09 | 50,440 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-02 | S | D | 885 | $63.16 | 50,440 | D | — | — | |
| 3 | Common | Common Stock | 2026-01-02 | M | A | 885 | $37.63 | 51,325 | D | — | — | |
| 4 | Derivative | Incentive Stock Option (Right to Buy) | 2026-01-02 | M | D | 885 | $0.00 | 1,772 | D | $37.63 · 2025-04-01 to 2032-03-01 | 885 Common Stock |